1. Home
  2. SCHL vs FTRE Comparison

SCHL vs FTRE Comparison

Compare SCHL & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scholastic Corporation

SCHL

Scholastic Corporation

HOLD

Current Price

$40.47

Market Cap

842.4M

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$13.30

Market Cap

829.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCHL
FTRE
Founded
1920
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Books
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
842.4M
829.3M
IPO Year
1995
2023

Fundamental Metrics

Financial Performance
Metric
SCHL
FTRE
Price
$40.47
$13.30
Analyst Decision
Hold
Buy
Analyst Count
1
9
Target Price
$40.00
$14.06
AVG Volume (30 Days)
321.4K
1.5M
Earning Date
03-19-2026
05-05-2026
Dividend Yield
1.99%
N/A
EPS Growth
N/A
N/A
EPS
1.87
N/A
Revenue
$1,487,100,000.00
$2,723,400,000.00
Revenue This Year
$1.88
N/A
Revenue Next Year
$4.05
$3.09
P/E Ratio
$21.44
N/A
Revenue Growth
N/A
1.00
52 Week Low
$16.81
$3.97
52 Week High
$43.39
$18.67

Technical Indicators

Market Signals
Indicator
SCHL
FTRE
Relative Strength Index (RSI) 56.08 55.18
Support Level $37.70 $8.85
Resistance Level $43.39 $18.26
Average True Range (ATR) 1.25 0.78
MACD -0.04 -0.23
Stochastic Oscillator 92.27 9.69

Price Performance

Historical Comparison
SCHL
FTRE

About SCHL Scholastic Corporation

Scholastic Corp is an American publishing and education media company that focuses on books and educational material for schools, teachers, parents, and children. It creates print, digital, and audiobooks, learning materials and programs, classroom magazines, and other products that support children's learning and reading both at home and at school. The company also owns rights to various books, including Harry Potter, Dog Man, and The Hunger Games among others. It has three reportable segments Children's Book Publishing and Distribution, Education Solutions, and International. The majority of its revenue is from the Children's Book Publishing and Distribution segment.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: